A detailed history of Hrt Financial LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 96,409 shares of EWTX stock, worth $2.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
96,409
Holding current value
$2.97 Million
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.88 - $29.5 $1.53 Million - $2.84 Million
96,409 New
96,409 $2.57 Million
Q4 2023

Feb 09, 2024

BUY
$5.51 - $12.1 $213,721 - $469,334
38,788 New
38,788 $424,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.94B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.